VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics
VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics
批准号:
10705645
负责人:
Daniel Hal Solomon
金额:
$89.11万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-09-15 至 2027-08-31
关键词:
AdultBehavioralBioinformaticsCOVID-19 pandemicCase StudyChildhoodClinicalClinical InvestigatorClinical ResearchCommunitiesConduct Clinical TrialsDataEconomicsEnsureFacultyFutureGrantHospitalsInterventionJournalsLearningMachine LearningMentorsMentorshipMethodologyMethodsMusculoskeletalMusculoskeletal DiseasesNational Institute of Arthritis, and Musculoskeletal, and Skin DiseasesPaperPatientsPerceptionPersonsPhenotypeProductivityPublicationsResearchResearch PersonnelResearch Project GrantsResearch SupportResearch TrainingResourcesRheumatismRheumatologyServicesStreamTrainingUnderrepresented MinorityWomanWorkadvanced analyticsbehavioral economicsbioinformatics resourcecohortdata integrationdesignethnic minorityimproved outcomeminority investigatornext generationphenotypic dataprogramsracial minorityrecruitresearch studyrheumatologistservice utilizationskillssocial health determinantssuccesstheoriestooltreatment effect
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The overarching long-term aims of VERITY are: 1) to develop state-of-the-art methods for clinical research in
rheumatology and musculoskeletal diseases that are relevant for the Research Community, 2) to deliver
methodologic and bioinformatic assistance to the Research Community, and 3) to train the Research
Community in state-of-the-art methods through courses, seminars, and mentoring. During the last cycle,
VERITY recruited a large and growing Research Community of rheumatic and MSK disease investigators who
participate in courses, mentoring, and utilize the services of the three VERITY Cores. The Overall Section of
the application describes: the progress and future directions for VERITY’s burgeoning Research Community;
how VERITY has developed and delivered courses to respond to the Research Community’s needs, especially
during the COVID pandemic; plans for future courses and mentoring of trainees and junior faculty; and the
services offered and organization of the Methodology Core and the Bioinformatics Core. During the previous
cycle, VERITY developed a diverse Research Community that has included many junior faculty and trainees, a
good number of pediatric rheumatologists, and an increasing group of MSK investigators. These researchers
represent the tremendous diversity of clinical investigators engaged with NIAMS-focused topics. In addition,
the large group of investigators helps provide the Cores with a steady stream of activity and resources.
During the prior cycle of the BWH CCCR, VERITY helped produce 160 original articles already cited 1,287
times. These original articles appeared in high impact journals. The VERITY Research Community has
been successful with 109 grant submissions during the last 4+ years, tabulating a total of $40,073,225
in annual direct research revenues. The three Cores have been extremely productive and learned much
about working effectively with the Research Community. The proposed aims build on the prior successes with:
an enhanced Enrichment Program increasing the focus on URiM researchers in rheumatology; a Methodology
Core that ensures methodologic rigor while incorporating behavioral theory and economics into studies
focused on racial and ethnic minorities; and a Bioinformatics Core that provides bioinformatic support to better
phenotype patient cohorts, allowing for studies of social determinants of health.
期刊论文(69)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.2196/45662
发表时间:
2023-05-25
期刊:
Journal of medical Internet research
影响因子:
7.4
作者:
[]
通讯作者:
DOI:
10.1016/j.joca.2020.10.001
发表时间:
2021-01
期刊:
Osteoarthritis and cartilage
影响因子:
7
作者:
[Sullivan JK, Huizinga J, Edwards RR, Hunter DJ, Neogi T, Yelin E, Katz JN, Losina E]
通讯作者:
Losina E
DOI:
10.1038/s41746-021-00519-z
发表时间:
2021-10-27
期刊:
NPJ digital medicine
影响因子:
15.2
作者:
[Hong C, Rush E, Liu M, Zhou D, Sun J, Sonabend A, Castro VM, Schubert P, Panickan VA, Cai T, Costa L, He Z, Link N, Hauser R, Gaziano JM, Murphy SN, Ostrouchov G, Ho YL, Begoli E, Lu J, Cho K, Liao KP, Cai T, VA Million Veteran Program]
通讯作者:
VA Million Veteran Program
External Validation of a Risk Score for Major Toxicity Among Nonsteroidal Anti-Inflammatory Drug Users: Real-World Application.
非甾体抗炎药使用者主要毒性风险评分的外部验证:现实世界应用。
DOI:
10.1002/acr2.11134
发表时间:
2020
期刊:
ACR open rheumatology
影响因子:
3.4
作者:
[Solomon,DanielH, Paynter,NinaP, Guan,Hongshu, Kremer,JoelM]
通讯作者:
Kremer,JoelM
Physician Prescribing Patterns and Risk of Future Long-Term Opioid Use Among Patients With Rheumatoid Arthritis: A Prospective Observational Cohort Study.
类风湿关节炎患者的医生处方模式和未来长期使用阿片类药物的风险:一项前瞻性观察队列研究。
DOI:
10.1002/art.41240
发表时间:
2020
期刊:
Arthritis & rheumatology (Hoboken, N.J.)
影响因子:
--
作者:
[Lee,YvonneC, Lu,Bing, Guan,Hongshu, Greenberg,JeffreyD, Kremer,Joel, Solomon,DanielH]
通讯作者:
Solomon,DanielH
共 45 条
Rheumatoid Arthritis and the Risk of Cardiovascular Disease: Biomarkers Risk Prediction and Underlying Mechanisms
-
批准号:10416473
-
项目类别:
-
资助金额:$68.32万
-
财政年份:2022
-
负责人:Daniel Hal Solomon
-
依托单位:
Rheumatoid Arthritis and the Risk of Cardiovascular Disease: Biomarkers Risk Prediction and Underlying Mechanisms
-
批准号:10643971
-
项目类别:
-
资助金额:$74.63万
-
财政年份:2022
-
负责人:Daniel Hal Solomon
-
依托单位:
VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics
-
批准号:9768189
-
项目类别:
-
资助金额:$89.49万
-
财政年份:2017
-
负责人:Daniel Hal Solomon
-
依托单位:
VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics
-
批准号:10017653
-
项目类别:
-
资助金额:$89.39万
-
财政年份:2017
-
负责人:Daniel Hal Solomon
-
依托单位:
Administrative Core
-
批准号:10705713
-
项目类别:
-
资助金额:$30.16万
-
财政年份:2017
-
负责人:Daniel Hal Solomon
-
依托单位:
VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics
-
批准号:9413618
-
项目类别:
-
资助金额:$90.75万
-
财政年份:2017
-
负责人:Daniel Hal Solomon
-
依托单位:
VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics
-
批准号:10251973
-
项目类别:
-
资助金额:$88.87万
-
财政年份:2017
-
负责人:Daniel Hal Solomon
-
依托单位:
Administrative Core
-
批准号:10251977
-
项目类别:
-
资助金额:$30.84万
-
财政年份:2017
-
负责人:Daniel Hal Solomon
-
依托单位:
Administrative Core
-
批准号:10017666
-
项目类别:
-
资助金额:$31.27万
-
财政年份:2017
-
负责人:Daniel Hal Solomon
-
依托单位:
Towards Evidence-Based Monitoring of Low Dose Methotrexate: CIRT Ancillary Study
-
批准号:9272426
-
项目类别:
-
资助金额:$84.03万
-
财政年份:2014
-
负责人:Daniel Hal Solomon
-
依托单位:
Towards Evidence-Based Monitoring of Low Dose Methotrexate: CIRT Ancillary Study
-
批准号:8760929
-
项目类别:
-
资助金额:$69.39万
-
财政年份:2014
-
负责人:Daniel Hal Solomon
-
依托单位:
Rheumatic expertise expanded access to improve community health REACH-RA
-
批准号:8293775
-
项目类别:
-
资助金额:$37.59万
-
财政年份:2012
-
负责人:Daniel Hal Solomon
-
依托单位:
Hydroxychloroquine to Improve Insulin Sensitivity in Rheumatoid Arthritis
-
批准号:8013621
-
项目类别:
-
资助金额:$20.57万
-
财政年份:2010
-
负责人:Daniel Hal Solomon
-
依托单位:
Hydroxychloroquine to Improve Insulin Sensitivity in Rheumatoid Arthritis
-
批准号:7774466
-
项目类别:
-
资助金额:$17.36万
-
财政年份:2010
-
负责人:Daniel Hal Solomon
-
依托单位:
Osteonecrosis of the Jaw in Non-Cancer Patients Using Bisphosphonates
-
批准号:7659840
-
项目类别:
-
资助金额:$26.68万
-
财政年份:2009
-
负责人:Daniel Hal Solomon
-
依托单位:
Modifiable Disparities in Treatment for Rheumatoid Arthritis
-
批准号:7690625
-
项目类别:
-
资助金额:$36.3万
-
财政年份:2009
-
负责人:Daniel Hal Solomon
-
依托单位:
Modifiable Disparities in Treatment for Rheumatoid Arthritis
-
批准号:8116558
-
项目类别:
-
资助金额:$58.48万
-
财政年份:2009
-
负责人:Daniel Hal Solomon
-
依托单位:
Modifiable Disparities in Treatment for Rheumatoid Arthritis
-
批准号:7891330
-
项目类别:
-
资助金额:$38.42万
-
财政年份:2009
-
负责人:Daniel Hal Solomon
-
依托单位:
Modifiable Disparities in Treatment for Rheumatoid Arthritis
-
批准号:8298604
-
项目类别:
-
资助金额:$58.34万
-
财政年份:2009
-
负责人:Daniel Hal Solomon
-
依托单位:
Estimating and Communicating Risk about Biologic DMARDs for Rheumatoid Arthritis
-
批准号:8278595
-
项目类别:
-
资助金额:$15.03万
-
财政年份:2008
-
负责人:Daniel Hal Solomon
-
依托单位:
国内基金
海外基金
Behavioral Insights on Cooperation in Social Dilemmas
-
批准号:--
-
项目类别:外国优秀青年学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:LIEN,Jaimie Wei-Hung
-
依托单位: